Current evidence does not suggest the importance of Covid-19 booster jabs in the general public, according to a new report from a group of leading scientists.
The researchers analyzed clinical trials and said the findings did not provide reliable evidence of a reduction in immunity to acute infections after inoculation.
The report, which was published in the medical journal The Lancet on Monday, was compiled by statistics including Soumya Swaminathan of the World Health Organization, Ana-Maria Henao-Restrepo and Mike Ryan.
“While the benefits of the first Covid-19 vaccine are clearly risky, there could be risks if the supplement is introduced sooner, or more frequently,” the scientists said.
“The current evidence does not seem to reflect the need for population growth, as the capacity to fight malnutrition remains strong,” he added.
A recent study of what happened to Israel in the first three weeks of August “showed that a third force could work”, compared to the two nations.
But short-term protection will not mean long-term gains, the researchers said.
According to reports, the effectiveness of antiretroviral therapy in Israel was lower among people who received the vaccine in January or April than those who received the vaccine in February or March, “indicating difficulties in translating this”.
The scientists carefully and publicly researched the study to ensure that decisions on promotion were informed by a reliable science and not by politics.
“While promotions have been shown to reduce the risk of developing chronic diseases, the current vaccine could save more lives if used in non-vaccinated people than it could be used as a vaccine for vaccinated people,” the scientists said.